FOMX
Alyeska Investment Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-205,870
| Closed | -$955K | – | 547 |
|
|
2017
Q2 | $955K | Sell |
205,870
-296,709
| -59% | -$1.38M | 0.01% | 395 |
|
|
2017
Q1 | $2.49M | Sell |
502,579
-151,262
| -23% | -$749K | 0.02% | 366 |
|
|
2016
Q4 | $7.26M | Buy |
653,841
+3,716
| +0.6% | +$41.3K | 0.06% | 292 |
|
|
2016
Q3 | $6.02M | Buy |
650,125
+80,722
| +14% | +$747K | 0.06% | 301 |
|
|
2016
Q2 | $3.62M | Buy |
569,403
+11,554
| +2% | +$73.4K | 0.03% | 323 |
|
|
2016
Q1 | $3.64M | Buy |
557,849
+17,247
| +3% | +$112K | 0.03% | 294 |
|
|
2015
Q4 | $4.38M | Buy |
540,602
+30,411
| +6% | +$247K | 0.05% | 262 |
|
|
2015
Q3 | $3.74M | Buy |
510,191
+39,093
| +8% | +$287K | 0.04% | 279 |
|
|
2015
Q2 | $4.83M | Buy |
471,098
+270,028
| +134% | +$2.77M | 0.05% | 261 |
|
|
2015
Q1 | $1.86M | Buy |
201,070
+14,781
| +8% | +$137K | 0.03% | 356 |
|
|
2014
Q4 | $1.31M | Buy |
186,289
+3,680
| +2% | +$25.8K | 0.02% | 359 |
|
|
2014
Q3 | $995K | Buy |
+182,609
| New | +$995K | 0.02% | 310 |
|